SEOUL, South Korea, Jan. 7, 2026 /PRNewswire/ -- STARMED, a pioneer in innovative minimally invasive treatment solutions, has announced a comprehensive rebranding. Now in its seventeenth year of ...
Infectious endocarditis (IE) represents a severe medical condition marked by infectious inflammation of the heart's inner ...
AI therapeutics company built on causal biology, today announced the acquisition of CombinAbleAI and the launch of insitro's TherML™ (Therapeutic Machine Learning) platform. The acquisition, which is ...
Join the event trusted by enterprise leaders for nearly two decades. VB Transform brings together the people building real enterprise AI strategy. Learn more Multi-modal models that can process both ...
Additional oral presentations explore odronextamab in areas of high unmet need, including the primary analysis in diffuse large B-cell lymphoma progressing after CAR-T therapy and first results in ...
Multi-modal Speech Transformer Decoders: When Do Multiple Modalities Improve Accuracy? Authors: Guan, Y., Trinh, V.A., Voleti, V., and Whitehill, J.
Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Vivek Yadav, an engineering manager from ...
The newly FDA-cleared uMR ® Ultra and the uOmniscan™ are the first major announcements leading into the AHRA Annual Meeting in Las Vegas. HOUSTON, Aug. 3, 2025 /PRNewswire/ -- United Imaging, a global ...
Oral presentation shares head-to-head results for investigational combination pozelimab plus cemdisiran vs. ravulizumab in paroxysmal nocturnal hemoglobinuria Initial results for odronextamab in first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback